BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Limmathurotsakul D, Chaowagul W, Chantratita N, Wuthiekanun V, Biaklang M, Tumapa S, White NJ, Day NP, Peacock SJ. A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis. PLoS Negl Trop Dis 2008;2:e327. [PMID: 18958279 DOI: 10.1371/journal.pntd.0000327] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Gonzalez-Juarrero M, Mima N, Trunck LA, Schweizer HP, Bowen RA, Dascher K, Mwangi W, Eckstein TM. Polar lipids of Burkholderia pseudomallei induce different host immune responses. PLoS One 2013;8:e80368. [PMID: 24260378 DOI: 10.1371/journal.pone.0080368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
2 Thomas RJ, Hamblin KA, Armstrong SJ, Müller CM, Bokori-brown M, Goldman S, Atkins HS, Titball RW. Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei. International Journal of Antimicrobial Agents 2013;41:330-6. [DOI: 10.1016/j.ijantimicag.2012.12.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
3 Micheva-Viteva S, Hong-Geller E. What Can Go Wrong When Applying Immune Modulation Therapies to Target Persistent Bacterial Infections. J Cell Immunol 2020;2:1-5. [PMID: 32395721 DOI: 10.33696/immunology.2.011] [Reference Citation Analysis]
4 Anunnatsiri S, Chaowagul W, Teparrukkul P, Chetchotisakd P, Tanwisaid K, Khemla S, Narenpitak S, Pattarapongsin M, Kongsawasd W, Pisuttimarn P, Thipmontree W, Mootsikapun P, Chaisuksant S, Chierakul W, Day NPJ, Limmathurotsakul D. A Comparison Between 12 Versus 20 Weeks of Trimethoprim-Sulfamethoxazole as Oral Eradication Treatment for Melioidosis (12vs20): An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial. Clin Infect Dis 2020:ciaa1084. [PMID: 32725199 DOI: 10.1093/cid/ciaa1084] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mariappan V, Vellasamy KM, Barathan M, Girija ASS, Shankar EM, Vadivelu J. Hijacking of the Host's Immune Surveillance Radars by Burkholderia pseudomallei. Front Immunol 2021;12:718719. [PMID: 34456925 DOI: 10.3389/fimmu.2021.718719] [Reference Citation Analysis]
6 Zajdowicz SL, Jones-Carson J, Vazquez-Torres A, Jobling MG, Gill RE, Holmes RK. Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable marker. PLoS One 2011;6:e21523. [PMID: 21720554 DOI: 10.1371/journal.pone.0021523] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chantratita N, Tandhavanant S, Wikraiphat C, Trunck LA, Rholl DA, Thanwisai A, Saiprom N, Limmathurotsakul D, Korbsrisate S, Day NP, Schweizer HP, Peacock SJ. Proteomic analysis of colony morphology variants of Burkholderia pseudomallei defines a role for the arginine deiminase system in bacterial survival. J Proteomics 2012;75:1031-42. [PMID: 22062159 DOI: 10.1016/j.jprot.2011.10.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
8 Mathai K RT, Bhat KS, Ashraf M, Sarawag M, K P K. Melioidosis with a Pericardial Effusion, which Relapsed as a Chest Wall Abscess: A Rare Presentation. J Clin Diagn Res 2013;7:746-8. [PMID: 23730667 DOI: 10.7860/JCDR/2013/5215.2902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 Sarovich DS, Price EP, Limmathurotsakul D, Cook JM, Von Schulze AT, Wolken SR, Keim P, Peacock SJ, Pearson T. Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection. Infect Drug Resist 2012;5:129-32. [PMID: 22977307 DOI: 10.2147/IDR.S35529] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
10 Limmathurotsakul D, Paeyao A, Wongratanacheewin S, Saiprom N, Takpho N, Thaipadungpanit J, Chantratita N, Wuthiekanun V, Day NP, Peacock SJ. Role of Burkholderia pseudomallei biofilm formation and lipopolysaccharide in relapse of melioidosis. Clin Microbiol Infect 2014;20:O854-6. [PMID: 24602145 DOI: 10.1111/1469-0691.12614] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
11 Inglis TJ. The Treatment of Melioidosis. Pharmaceuticals (Basel) 2010;3:1296-303. [PMID: 27713302 DOI: 10.3390/ph3051296] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
12 Sarovich DS, Ward L, Price EP, Mayo M, Pitman MC, Baird RW, Currie BJ. Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare. J Clin Microbiol 2014;52:650-3. [PMID: 24478504 DOI: 10.1128/JCM.02239-13] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
13 Losada L, Shea AA, DeShazer D. A MarR family transcriptional regulator and subinhibitory antibiotics regulate type VI secretion gene clusters in Burkholderia pseudomallei. Microbiology (Reading) 2018;164:1196-211. [PMID: 30052173 DOI: 10.1099/mic.0.000697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
14 Klimko CP, Treviño SR, Moreau AM, Cuadrado MJA, Meyer JR, Fetterer DP, Welkos SL, Worsham PL, Kreiselmeier N, Soffler C, Cote CK. The Impact of Age and Sex on Mouse Models of Melioidosis. Pathogens 2020;9:E113. [PMID: 32054106 DOI: 10.3390/pathogens9020113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Limmathurotsakul D, Peacock SJ. Melioidosis: a clinical overview. Br Med Bull 2011;99:125-39. [PMID: 21558159 DOI: 10.1093/bmb/ldr007] [Cited by in Crossref: 164] [Cited by in F6Publishing: 148] [Article Influence: 14.9] [Reference Citation Analysis]
16 Price EP, Sarovich DS, Mayo M, Tuanyok A, Drees KP, Kaestli M, Beckstrom-Sternberg SM, Babic-Sternberg JS, Kidd TJ, Bell SC, Keim P, Pearson T, Currie BJ. Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. mBio 2013;4:e00388-13. [PMID: 23860767 DOI: 10.1128/mBio.00388-13] [Cited by in Crossref: 78] [Cited by in F6Publishing: 65] [Article Influence: 8.7] [Reference Citation Analysis]
17 Wiersinga WJ, Virk HS, Torres AG, Currie BJ, Peacock SJ, Dance DAB, Limmathurotsakul D. Melioidosis. Nat Rev Dis Primers 2018;4:17107. [PMID: 29388572 DOI: 10.1038/nrdp.2017.107] [Cited by in Crossref: 197] [Cited by in F6Publishing: 172] [Article Influence: 49.3] [Reference Citation Analysis]
18 Halim I, Shaw T, Tellapragada C, Vandana KE, Mukhopadhyay C. Melioidosis: Reinfection going incognito as relapse. Indian J Med Microbiol 2017;35:593-6. [PMID: 29405156 DOI: 10.4103/ijmm.IJMM_17_140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
19 Gassiep I, Armstrong M, Norton R. Human Melioidosis. Clin Microbiol Rev 2020;33:e00006-19. [PMID: 32161067 DOI: 10.1128/CMR.00006-19] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
20 Limmathurotsakul D, Chaowagul W, Day NP, Peacock SJ. Patterns of organ involvement in recurrent melioidosis. Am J Trop Med Hyg 2009;81:335-7. [PMID: 19635894 DOI: 10.4269/ajtmh.2009.81.335] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]